Use the search parameters below to filter talks:

Calendar
Calendar

2010 - TTS International Congress (Vancouver)

Clinical Immunosuppression Kidney early
15 August 2010  /  00:01 - 00:01

Clinical pharmacokinetics of tacrolimus in renal transplant patients and determination of best sampling time for correlation with drug exposure

Presenter: PILAR SALVADOR, A CORUÑA, Spain

- Clinical pharmacokinetics of tacrolimus in renal transplant patients and determination of best sampling time for correlation with drug exposure

Presenter: PILAR SALVADOR, A CORUÑA, Spain

The Effect of Immunosuppression on regeneration of the renal tubules

Presenter: Delawir Kahn, Cape Town, South Africa

- The Effect of Immunosuppression on regeneration of the renal tubules

Presenter: Delawir Kahn, Cape Town, South Africa

Evaluation of limited sampling strategies for tacrolimus (Prograf®) exposure in adult kidney transplant recipients

Presenter: Katherine Barraclough, Brisbane, Australia

- Evaluation of limited sampling strategies for tacrolimus (Prograf®) exposure in adult kidney transplant recipients

Presenter: Katherine Barraclough, Brisbane, Australia

Retrospective Analysis of Timing of Basiliximab Induction and Effect on One Year Outcomes Following Kidney Transplantation

Presenter: S Joseph Kim, Toronto, Canada

- Retrospective Analysis of Timing of Basiliximab Induction and Effect on One Year Outcomes Following Kidney Transplantation

Presenter: S Joseph Kim, Toronto, Canada

Pharmacokinetics of Once-Daily Tacrolimus Extended Release (TER) in de novo Renal Transplantation induction immunotherapy.

Presenter: Kazunari Yoshida, Sagamihara, Japan

- Pharmacokinetics of Once-Daily Tacrolimus Extended Release (TER) in de novo Renal Transplantation induction immunotherapy.

Presenter: Kazunari Yoshida, Sagamihara, Japan

Mycophenolate sodium dosing in combination with tacrolimus: Pharmacokinetic evaluation of a novel regimen in de novo kiney transplant patients.

Presenter: Bertrand Pons, SAINT PRIEST EN JAREZ, France

- Mycophenolate sodium dosing in combination with tacrolimus: Pharmacokinetic evaluation of a novel regimen in de novo kiney transplant patients.

Presenter: Bertrand Pons, SAINT PRIEST EN JAREZ, France

Routine reduction in mycophenolate mofetil from 1g twice daily to 0.5g twice daily after the first 30 days does not compromise short term outcome.

Presenter: Andrew Watts, London,

- Routine reduction in mycophenolate mofetil from 1g twice daily to 0.5g twice daily after the first 30 days does not compromise short term outcome.

Presenter: Andrew Watts, London,

Pharmacodynamic Evaluation of Cyclosporine in B-cell

Presenter: Takafumi Kuzuya, Nagoya, Japan

- Pharmacodynamic Evaluation of Cyclosporine in B-cell

Presenter: Takafumi Kuzuya, Nagoya, Japan

Steroid Free Immunosuppression in Kidney Transplantation : initial experience in Asian Indian population

Presenter: Sanjeev Gulati, NEW DELHI, India

- Steroid Free Immunosuppression in Kidney Transplantation : initial experience in Asian Indian population

Presenter: Sanjeev Gulati, NEW DELHI, India

PRCA successfully treated with immunosuppression followed by kidney transplantation

Presenter: Wladyslaw Sulowicz, Krakow, Poland

- PRCA successfully treated with immunosuppression followed by kidney transplantation

Presenter: Wladyslaw Sulowicz, Krakow, Poland

Very early CsA reduction synchronizes with de novo everolimus therapy in kidney transplant recipients: a four year follow up with pharmacokinetic study.

Presenter: Vasant Sumethkul, Bangkok, Thailand

- Very early CsA reduction synchronizes with de novo everolimus therapy in kidney transplant recipients: a four year follow up with pharmacokinetic study.

Presenter: Vasant Sumethkul, Bangkok, Thailand

short-term clinical result to use of extended release tacrolimus in kidney transplant recipients

Presenter: Jesus Bustamante Bustamante, Valladolid, Spain

- short-term clinical result to use of extended release tacrolimus in kidney transplant recipients

Presenter: Jesus Bustamante Bustamante, Valladolid, Spain

Clinically Better Renal Function With Everolimus and Very Low Tacrolimus Exposure in De novo Renal Transplant Recipients at 12 Months: The ASSET Study

Presenter: Maarten Christiaans, Maastricht, Netherlands

- Clinically Better Renal Function With Everolimus and Very Low Tacrolimus Exposure in De novo Renal Transplant Recipients at 12 Months: The ASSET Study

Presenter: Maarten Christiaans, Maastricht, Netherlands

Comparable Patient Reported Outcomes with Initially Intensified Dosing versus Standard Dosing of Enteric-Coated Mycophenolate Sodium (EC-MPS) in De Novo Renal Transplant Recipients

Presenter: Bryce Kiberd, Halifax, Canada

- Comparable Patient Reported Outcomes with Initially Intensified Dosing versus Standard Dosing of Enteric-Coated Mycophenolate Sodium (EC-MPS) in De Novo Renal Transplant Recipients

Presenter: Bryce Kiberd, Halifax, Canada

Evaluation of the pharmacokinetics of prednisolone and limited sampling strategies for estimation of prednisolone exposure in adult kidney transplant recipients

Presenter: Katherine Barraclough, Brisbane, Australia

- Evaluation of the pharmacokinetics of prednisolone and limited sampling strategies for estimation of prednisolone exposure in adult kidney transplant recipients

Presenter: Katherine Barraclough, Brisbane, Australia

Everolimus Allows For A 60% Reduction in Cyclosporine Exposure in Subject Cohorts defined by Geography

Presenter: R Walker, Melbourne, Australia

- Everolimus Allows For A 60% Reduction in Cyclosporine Exposure in Subject Cohorts defined by Geography

Presenter: R Walker, Melbourne, Australia

Differential effects of immunosuppressive agents on renal function after ischemia-reperfusion injury: New insights by using 99mTc-MAG3 imaging

Presenter: Tanja Herrler, Munich, Afghanistan

- Differential effects of immunosuppressive agents on renal function after ischemia-reperfusion injury: New insights by using 99mTc-MAG3 imaging

Presenter: Tanja Herrler, Munich, Afghanistan

An Intensified Dosing Of Enteric-Coated Mycophenolate Sodium In Renal Transplant Patients Results In Improved Efficacy Without Compromising Safety: 1 Year Follow-Up Results

Presenter: Wolfgang Arns, Koeln-Merheim, Germany

- An Intensified Dosing Of Enteric-Coated Mycophenolate Sodium In Renal Transplant Patients Results In Improved Efficacy Without Compromising Safety: 1 Year Follow-Up Results

Presenter: Wolfgang Arns, Koeln-Merheim, Germany

Kidney transplantation outcomes of crossmatch positive and ABO-incompatible patients. Single center experience

Presenter: Kumar Gaurav, Charlottesville, United States

- Kidney transplantation outcomes of crossmatch positive and ABO-incompatible patients. Single center experience

Presenter: Kumar Gaurav, Charlottesville, United States

Renal Function of an Everolimus based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients One Year After Conversion

Presenter: Klemens Budde, Berlin, Germany

- Renal Function of an Everolimus based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients One Year After Conversion

Presenter: Klemens Budde, Berlin, Germany

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi